SCHEMBL5440775

SCHEMBL5440775

N#Cc1ccc(N(C(=O)c2cc3cc(N)ccc3s2)n2ccnc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 4/20 0.39
CYP19A1 P11511 4/20 0.39
TBXAS1 P24557 4/20 0.38
STS P08842 1/20 0.36
CHRNA7 P36544 1/20 0.36
DYRK1A Q13627 1/20 0.34
DYRK1B Q9Y463 1/20 0.34
CD38 P28907 1/20 0.34
FNTA P49354 1/20 0.34
FNTB P49356 1/20 0.34
NAMPT P43490 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
ICAM1 P05362 1/20 0.32
SELE P16581 1/20 0.32
VCAM1 P19320 1/20 0.32
CCNC P24863 1/20 0.32
CDK8 P49336 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5440915 0.87 KMT2A (0.48) CLK1CYP19A1TBXAS1CYP2C19LMNA
SCHEMBL5440768 0.86 CA1 (0.39) CLK1CYP19A1TBXAS1STSDYRK1A
SCHEMBL5441196 0.70 CYP19A1 (0.46) CYP19A1TBXAS1STSCD38LMNA
SCHEMBL5445776 0.69 CYP19A1 (0.47) CYP19A1STSCD38
SCHEMBL5435456 0.68 MEN1 (0.41) CYP19A1STSCD38LMNA
SCHEMBL5474421 0.66 CD38 (0.46) CYP19A1CD38NAMPTLMNA
SCHEMBL5441208 0.65 CYP19A1 (0.50) CYP19A1STS
SCHEMBL5449289 0.65 CYP19A1 (0.43) CYP19A1STSCD38
SCHEMBL5439309 0.65 CYP19A1 (0.47) CYP19A1STS
SCHEMBL5435417 0.64 CYP19A1 (0.48) CYP19A1TBXAS1STS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476455-B2 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them LABORATOIRE THERAMEX (MC) 2013-07-02 US disclosed
US-20070112009-A1 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them LABORATOIRE THERAMEX (MC) 2007-05-17 US disclosed
EP-1694650-A1 1-N-PHENYL-AMINO-1H-IMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LABORATOIRE THERAMEX (MC) 2006-08-30 EP disclosed
WO-2005058842-A1 1-N-PHENYL-AMINO-1H-IMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LABORATOIRE THERAMEX (MC) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112009-A1 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them H1-0, H1-5, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 CLK1 3689/4885CYP19A1 761/4885TBXAS1 423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.